Effect of oral administration of a prostacyclin analog (OP-41483) on pulmonary function and bronchial responsiveness in stable asthmatic subjects

J Asthma. 1991;28(6):419-24. doi: 10.3109/02770909109110624.

Abstract

To examine whether prostacyclin has an attenuating effect on nonspecific bronchial responsiveness in asthma, we measured provocative concentration of methacholine producing a 20% fall in forced expiratory volume in 1 second (PC20-FEV1) before and after oral administration of a chemically stable prostacyclin analog (OP-41483) (200 micrograms 4 times a day for 4 days) in 8 patients with stable asthma. Neither baseline pulmonary function nor PC20-FEV1 significantly improved after the treatment. These results suggest that prostacyclin may have no direct effect on bronchial responsiveness in asthmatics. Further studies using more potent and long-lasting prostacyclin mimetic will be needed to confirm the conclusion.

MeSH terms

  • Acetylcholine
  • Administration, Oral
  • Asthma / drug therapy
  • Asthma / physiopathology*
  • Bronchial Hyperreactivity / physiopathology*
  • Bronchial Provocation Tests
  • Epoprostenol / administration & dosage
  • Epoprostenol / analogs & derivatives*
  • Epoprostenol / physiology
  • Epoprostenol / therapeutic use
  • Forced Expiratory Volume / drug effects
  • Humans
  • Middle Aged
  • Prostaglandins, Synthetic / administration & dosage
  • Prostaglandins, Synthetic / therapeutic use*

Substances

  • Prostaglandins, Synthetic
  • Epoprostenol
  • ataprost
  • Acetylcholine